1. Home
  2. WAY vs TNGX Comparison

WAY vs TNGX Comparison

Compare WAY & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

N/A

Current Price

$26.46

Market Cap

4.8B

Sector

N/A

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

BUY

Current Price

$22.53

Market Cap

4.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
WAY
TNGX
Founded
1999
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
WAY
TNGX
Price
$26.46
$22.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
12
Target Price
$33.77
★ $45.18
AVG Volume (30 Days)
2.0M
★ 2.9M
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 569.23
26.89
EPS
★ 0.43
N/A
Revenue
★ $1,099,278,000.00
$62,384,000.00
Revenue This Year
$17.00
N/A
Revenue Next Year
$10.69
N/A
P/E Ratio
$59.86
★ N/A
Revenue Growth
16.50
★ 48.29
52 Week Low
$17.26
$6.69
52 Week High
$39.99
$34.39

Technical Indicators

Market Signals
Indicator
WAY
TNGX
Relative Strength Index (RSI) 58.92 42.21
Support Level $23.64 $21.63
Resistance Level $26.70 $26.05
Average True Range (ATR) 1.10 1.60
MACD 0.07 -0.16
Stochastic Oscillator 87.05 28.04

Price Performance

Historical Comparison
WAY
TNGX

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: